Discounted Cash Flow Rating
Sell
Return on Equity Rating
Strong Buy
Debt to Equity Rating
Strong Sell
Price to Earnings Rating
Buy
Analyst Rating
Sell
Simple Moving Average
Buy
Exponential Moving Average
Buy
Relative Strength Index
Buy
Standard Deviation
Strong Buy
Williams %R
Strong Buy
Average Directional Index
Neutral
Insider Trading
Strong Buy
Wall Street Data Solutions Rating
Buy
A
T2 Biosystems, Inc (TTOO)
Surgical & Medical Instruments & Apparatus
T2 Biosystems Inc provides rapid in vitro diagnostic tests to hospitals and laboratories. The company's core technology is T2 Magnetic Resonance (T2MR) technology, which can detect a variety of molecular targets directly from whole blood. T2MR technology enables the T2Dx system, which is fully automated from patient sample to result for its panels focused on bacterial and fungal infections that could cause sepsis, and its pipeline panel for Lyme disease.
101 HARTWELL AVENUE
LEXINGTON, MA
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
08/07/2014
Market Cap
65,375,200
Shares Outstanding
4,050,000
Weighted SO
4,050,294
Total Employees
N/A
Upcoming Earnings
08/05/2024
Similar Tickers
Beta
0.1350
Last Div
0.0000
Range
2.6-63.5
Chg
0.1850
Avg Vol
136651
Mkt Cap
65375200
Exch
NASDAQ
Country
US
Phone
781 761 4646
DCF Diff
3.1709
DCF
-0.1812
Div Yield
0.0000
P/S
9.1255
EV Multiple
-1.7845
P/FV
-8.9380
Div Yield %
0.0000
P/E
-1.0860
PEG
-0.0653
Payout
0.0000
Current Ratio
0.5962
Quick Ratio
0.3591
Cash Ratio
0.1948
DSO
66.0811
DIO
140.0865
Op Cycle
206.1676
DPO
45.6928
CCC
160.4748
Gross Margin
-0.8800
Op Margin
-6.2955
Pretax Margin
-6.7758
Net Margin
-6.7758
Eff Tax Rate
0.0777
ROA
-2.2348
ROE
2.1351
ROCE
578.2179
NI/EBT
1.0000
EBT/EBIT
1.0763
EBIT/Rev
-6.2955
Debt Ratio
0.8849
D/E
-3.2587
LT Debt/Cap
-37.8026
Total Debt/Cap
1.4427
Int Coverage
27.9263
CF/Debt
-2.2754
Equity Multi
-3.6828
Rec Turnover
5.5235
Pay Turnover
7.9881
Inv Turnover
2.6055
FA Turnover
0.8765
Asset Turnover
0.3298
OCF/Share
-3.1027
FCF/Share
-3.1054
Cash/Share
0.3012
OCF/Sales
-6.1046
FCF/OCF
1.0009
CF Coverage
-2.2754
ST Coverage
-3.2457
CapEx Coverage
-1121.3590
Div&CapEx Cov
-1121.3590
P/BV
-8.9380
P/B
-8.9380
P/S
9.1255
P/E
-1.0860
P/FCF
-1.4935
P/OCF
-1.2054
P/CF
-1.2054
PEG
-0.0653
P/S
9.1255
EV Multiple
-1.7845
P/FV
-8.9380
DPS
0.0000
Latest Headlines (EST)
Revenue Product Segmentation
Year | Purchases | Sales | Total Bought | Total Sold |
---|
Transaction Date | Name | Type Of Owner | Price | Securities Owned | Securities Transacted | Security Name | Transaction Type |
---|
Less Than 3 Months
9.87M Shares Bought (99.72 %)
28.04K Shares Sold (0.28%)
3 - 6 Months
831.02K Shares Bought (90.94 %)
82.75K Shares Sold (9.06%)
6 - 9 Months
40.00 Shares Bought (0.00 %)
7.92M Shares Sold (100.00%)
9 - 12 Months
48.46M Shares Bought (57.90 %)
35.23M Shares Sold (42.10 %)
Investor Name | Investment Discretion | Type of Security | Shares Owned | Avg Price Paid | Market Value | Change In Market Value | Change In Market Value (%) | Ownership | Weight |
---|
Date | Investors Holding | Closed Positions | Increased Positions | Reduced Positions | New Positions | Total Invested | Put/Call Ratio | Total Calls | Total Puts |
---|
Owner | Shares Owned |
---|
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Revenue | 1.79M | ▲ 3.07M | ▲ 7.79M | ▼ 6.98M | ▼ 5.48M | ▼ 1.68M | ▲ 2.06M |
Cost Of Revenue | 5.63M | ▼ 3.61M | ▲ 7.48M | ▼ 5.36M | ▼ 3.77M | ▼ 2.65M | ▲ 4.20M |
Gross Profit | -3.84M | ▲ -541.00K | ▲ 312.00K | ▲ 1.62M | ▲ 1.72M | ▼ -969.00K | ▼ -2.14M |
Gross Profit Ratio | -2.14 | ▲ -0.18 | ▲ 0.04 | ▲ 0.23 | ▲ 0.31 | ▼ -0.58 | ▼ -1.04 |
Research And Development Expenses | 3.30M | ▲ 4.28M | ▼ 4.04M | ▲ 5.35M | ▼ 4.88M | ▼ 3.10M | ▲ 3.72M |
General And Administrative Expenses | 6.46M | ▲ 7.55M | ▲ 9.71M | ▼ 0.00 | ▲ 6.57M | ▼ 0.00 | 0.00 |
Selling And Marketing Expenses | 0.00 | 0.00 | ▼ -5.11M | ▲ 0.00 | ▲ 100.00K | ▼ 0.00 | 0.00 |
Selling General And Administrative Expenses | 6.46M | ▲ 7.55M | ▼ 4.60M | ▲ 6.54M | ▲ 6.67M | ▼ 5.26M | ▲ 6.74M |
Other Expenses | 217.00K | ▼ 17.00K | ▼ 9.00K | ▼ -5.00K | ▲ 96.00K | ▲ 109.00K | ▲ 325.00K |
Operating Expenses | 9.76M | ▲ 11.83M | ▼ 8.63M | ▲ 11.90M | ▼ 11.55M | ▼ 8.35M | ▲ 10.46M |
Cost And Expenses | 15.39M | ▲ 15.44M | ▲ 16.11M | ▲ 17.26M | ▼ 15.32M | ▼ 11.00M | ▲ 14.66M |
Interest Income | 0.00 | 0.00 | 0.00 | ▲ 94.00K | ▼ 2.00K | ▼ -4.00K | ▲ 0.00 |
Interest Expense | 1.77M | ▼ 1.69M | ▼ 1.60M | ▲ 1.95M | ▼ 1.53M | ▼ 1.16M | ▼ -1.18M |
Depreciation And Amortization | 587.00K | ▲ 883.00K | ▼ 684.00K | ▼ 556.00K | ▼ 98.00K | ▼ 74.00K | ▼ 64.00K |
Ebitda | -12.79M | ▲ -12.35M | ▲ -8.31M | ▼ -10.19M | ▲ -9.74M | ▲ -9.25M | ▼ -12.60M |
Ebitda Ratio | -7.14 | ▲ -4.02 | ▲ -1.07 | ▼ -1.46 | ▼ -1.78 | ▼ -5.51 | ▼ -6.11 |
Operating Income | -13.59M | ▲ -12.37M | ▲ -8.32M | ▼ -10.28M | ▲ -9.83M | ▲ -9.32M | ▼ -12.60M |
Operating Income Ratio | -7.59 | ▲ -4.03 | ▲ -1.07 | ▼ -1.47 | ▼ -1.79 | ▼ -5.55 | ▼ -6.11 |
Total Other Income Expenses Net | 217.00K | ▼ 17.00K | ▼ 9.00K | ▼ -5.00K | ▼ -579.00K | ▼ -1.02M | ▲ -934.00K |
Income Before Tax | -15.15M | ▲ -14.04M | ▲ -9.91M | ▼ -12.14M | ▲ -10.41M | ▲ -10.34M | ▼ -13.53M |
Income Before Tax Ratio | -8.45 | ▲ -4.58 | ▲ -1.27 | ▼ -1.74 | ▼ -1.90 | ▼ -6.16 | ▼ -6.57 |
Income Tax Expense | 1.99M | ▼ 824.00K | ▲ 923.00K | ▲ 1.95M | ▼ 1.04M | ▼ -3.38M | ▲ -64.00K |
Net Income | -15.15M | ▲ -14.04M | ▲ -9.91M | ▼ -12.14M | ▲ -11.45M | ▲ -10.34M | ▼ -13.53M |
Net Income Ratio | -8.45 | ▲ -4.58 | ▲ -1.27 | ▼ -1.74 | ▼ -2.09 | ▼ -6.16 | ▼ -6.57 |
Eps | -17.50 | ▲ -14.50 | ▲ -3.35 | ▼ -7.00 | ▼ -154.62 | ▲ -2.08 | ▼ -2.66 |
Eps Diluted | -17.50 | ▲ -14.50 | ▲ -3.35 | ▼ -7.00 | ▼ -154.62 | ▲ -2.08 | ▼ -2.66 |
Weighted Average Shs Out | 882.91K | ▼ 0.00 | ▲ 29.60K | ▲ 33.23K | ▲ 74.06K | ▲ 4.97M | ▲ 5.09M |
Weighted Average Shs Out Dil | 882.91K | ▼ 0.00 | ▲ 29.60K | ▲ 33.24K | ▲ 74.06K | ▲ 4.97M | ▲ 5.09M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Cash And Cash Equivalents | 50.81M | ▼ 11.03M | ▲ 16.79M | ▲ 22.25M | ▼ 10.33M | ▲ 15.69M | ▼ 6.21M |
Short Term Investments | 0.00 | 0.00 | ▲ 25.40M | ▼ 10.00M | ▼ 0.00 | 0.00 | 0.00 |
Cash And Short Term Investments | 50.81M | ▼ 11.03M | ▲ 42.19M | ▼ 32.24M | ▼ 10.33M | ▲ 15.69M | ▼ 6.21M |
Net Receivables | 1.79M | ▲ 2.83M | ▲ 5.10M | ▲ 5.13M | ▼ 2.16M | ▼ 1.42M | ▲ 1.59M |
Inventory | 2.68M | ▲ 3.60M | ▲ 3.64M | ▲ 3.91M | ▲ 4.35M | ▲ 4.82M | ▼ 4.67M |
Other Current Assets | 1.34M | ▲ 1.44M | ▲ 2.66M | ▲ 3.11M | ▼ 2.58M | ▲ 3.16M | ▼ 3.09M |
Total Current Assets | 56.61M | ▼ 18.90M | ▲ 53.58M | ▼ 44.39M | ▼ 19.42M | ▲ 25.09M | ▼ 15.56M |
Property Plant Equipment Net | 7.32M | ▲ 9.21M | ▲ 14.81M | ▼ 14.44M | ▼ 13.27M | ▼ 9.05M | ▼ 8.64M |
Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Goodwill And Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Long Term Investments | 0.00 | 0.00 | ▲ 10.00M | ▼ 0.00 | ▲ 1.65M | ▼ 651.00K | 651.00K |
Tax Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Non Current Assets | 386.00K | 386.00K | ▲ 687.00K | ▲ 1.70M | ▼ 43.00K | ▼ 4.00K | ▼ -98.00K |
Total Non Current Assets | 7.70M | ▲ 9.59M | ▲ 25.49M | ▼ 16.15M | ▼ 14.97M | ▼ 9.71M | ▼ 9.19M |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 1.00 | 1.00 |
Total Assets | 64.31M | ▼ 28.49M | ▲ 79.08M | ▼ 60.54M | ▼ 34.39M | ▲ 34.80M | ▼ 24.76M |
Account Payables | 744.00K | ▲ 3.75M | ▼ 2.06M | ▲ 2.83M | ▼ 1.30M | ▲ 1.53M | ▲ 1.89M |
Short Term Debt | 42.64M | ▲ 42.90M | ▼ 1.15M | ▲ 1.17M | ▲ 1.35M | ▲ 42.90M | ▲ 43.32M |
Tax Payables | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Revenue | 697.00K | ▼ 285.00K | ▼ 230.00K | ▲ 518.00K | ▼ 172.00K | ▲ 224.00K | ▼ 185.00K |
Other Current Liabilities | 8.22M | ▲ 13.63M | ▼ 6.36M | ▲ 7.16M | ▲ 7.69M | ▲ 11.50M | ▼ 10.87M |
Total Current Liabilities | 52.30M | ▲ 60.57M | ▼ 9.80M | ▲ 11.69M | ▼ 10.51M | ▲ 56.15M | ▲ 56.26M |
Long Term Debt | 492.00K | ▲ 1.87M | ▲ 55.77M | ▲ 57.15M | ▲ 57.87M | ▼ 6.60M | ▼ 6.18M |
Deferred Revenue Non Current | 133.00K | ▼ 46.00K | ▲ 424.00K | ▼ 28.00K | ▲ 52.00K | ▲ 83.00K | ▲ 92.00K |
Deferred Tax Liabilities Non Current | -492.00K | ▼ -1.87M | ▲ 1.01M | ▼ 0.00 | 0.00 | ▼ -6.60M | ▲ -92.00K |
Other Non Current Liabilities | 492.00K | ▲ 1.87M | ▲ 3.35M | ▲ 4.58M | ▲ 5.94M | ▲ 6.60M | ▼ 92.00K |
Total Non Current Liabilities | 625.00K | ▲ 1.92M | ▲ 60.55M | ▲ 61.75M | ▲ 63.85M | ▼ 6.68M | ▼ 6.27M |
Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 1.00 | 1.00 |
Capital Lease Obligations | 760.00K | ▲ 1.87M | ▲ 10.53M | ▼ 9.36M | ▲ 9.57M | ▼ 6.60M | ▼ 6.18M |
Total Liabilities | 52.92M | ▲ 62.49M | ▲ 70.35M | ▲ 73.44M | ▲ 74.36M | ▼ 62.83M | ▼ 62.53M |
Preferred Stock | 0.00 | ▲ 2.00K | ▼ 0.00 | 0.00 | 0.00 | ▲ 1.00 | ▼ 0.00 |
Common Stock | 44.00K | ▲ 49.00K | ▲ 147.00K | ▲ 166.00K | ▼ 8.00K | ▼ 4.00K | ▲ 6.00K |
Retained Earnings | -317.17M | ▼ -376.18M | ▼ -422.98M | ▼ -472.22M | ▼ -534.53M | ▼ -584.30M | ▼ -597.83M |
Accumulated Other Comprehensive Income Loss | -11.31M | ▼ -13.24M | ▲ 9.00K | ▼ -4.00K | ▲ 0.00 | 0.00 | 0.00 |
Other Total Stockholders Equity | 339.82M | ▲ 355.36M | ▲ 431.55M | ▲ 459.15M | ▲ 494.56M | ▲ 556.26M | ▲ 560.05M |
Total Stockholders Equity | 11.39M | ▼ -34.01M | ▲ 8.73M | ▼ -12.90M | ▼ -39.97M | ▲ -28.04M | ▼ -37.77M |
Total Equity | 11.39M | ▼ -34.01M | ▲ 8.73M | ▼ -12.90M | ▼ -39.97M | ▲ -28.04M | ▼ -37.77M |
Total Liabilities And Stockholders Equity | 64.31M | ▼ 28.49M | ▲ 79.08M | ▼ 60.54M | ▼ 34.39M | ▲ 34.80M | ▼ 24.76M |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Liabilities And Total Equity | 64.31M | ▼ 28.49M | ▲ 79.08M | ▼ 60.54M | ▼ 34.39M | ▲ 34.80M | ▼ 24.76M |
Total Investments | 0.00 | 0.00 | ▲ 35.40M | ▼ 10.00M | ▼ 1.65M | ▼ 651.00K | 651.00K |
Total Debt | 43.13M | ▲ 44.78M | ▲ 55.77M | ▲ 57.15M | ▲ 59.22M | ▼ 49.50M | ▼ 49.50M |
Net Debt | -7.67M | ▲ 33.74M | ▲ 38.98M | ▼ 34.90M | ▲ 48.89M | ▼ 33.81M | ▲ 43.29M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Net Income | -15.15M | ▲ -14.04M | ▲ -9.91M | ▼ -12.14M | ▲ -10.10M | ▼ -10.34M | ▼ -13.53M |
Depreciation And Amortization | 587.00K | ▲ 883.00K | ▼ 684.00K | ▼ 556.00K | ▲ 572.00K | ▼ 74.00K | ▼ 64.00K |
Deferred Income Tax | 597.00K | ▼ -178.00K | ▼ -225.00K | ▲ 0.00 | 0.00 | ▼ -923.00K | ▲ 0.00 |
Stock Based Compensation | 2.41M | ▼ 983.00K | ▼ 904.00K | ▲ 1.47M | ▼ 1.04M | ▼ 728.00K | ▲ 1.60M |
Change In Working Capital | 1.36M | ▲ 1.59M | ▼ -1.17M | ▲ -744.00K | ▼ -1.63M | ▲ -523.00K | ▼ -593.00K |
Accounts Receivables | -52.00K | ▼ -1.25M | ▲ -1.24M | ▲ -912.00K | ▲ -585.00K | ▲ -281.00K | ▲ -168.00K |
Inventory | 102.00K | ▲ 550.00K | ▼ -282.00K | ▲ -25.00K | ▼ -134.00K | ▼ -205.00K | ▲ 149.00K |
Accounts Payables | 161.00K | ▲ 277.00K | ▼ -371.00K | ▲ 238.00K | ▼ -775.00K | ▲ 439.00K | ▼ 358.00K |
Other Working Capital | 1.15M | ▲ 2.02M | ▼ 723.00K | ▼ -45.00K | ▼ -133.00K | ▼ -476.00K | ▼ -932.00K |
Other Non Cash Items | 503.00K | ▲ 644.00K | ▲ 965.00K | ▲ 1.02M | ▼ -210.00K | ▲ 1.57M | ▲ 2.17M |
Net Cash Provided By Operating Activities | -9.69M | ▼ -10.12M | ▲ -8.75M | ▼ -9.84M | ▼ -10.33M | ▲ -9.42M | ▼ -11.68M |
Investments In Property Plant And Equipment | 357.00K | ▼ -26.00K | ▼ -379.00K | ▲ -199.00K | ▲ -36.00K | ▲ -26.00K | ▲ 0.00 |
Acquisitions Net | 0.00 | 0.00 | ▼ -15.45M | ▲ 0.00 | 0.00 | 0.00 | 0.00 |
Purchases Of Investments | 0.00 | 0.00 | ▼ -249.00K | ▲ 0.00 | 0.00 | 0.00 | 0.00 |
Sales Maturities Of Investments | 0.00 | 0.00 | ▲ 7.00M | ▲ 10.00M | 10.00M | ▼ 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | ▲ 15.45M | ▼ 0.00 | ▼ -10.00M | ▲ 0.00 | 0.00 |
Net Cash Used For Investing Activities | 357.00K | ▼ -26.00K | ▲ 6.37M | ▲ 9.80M | ▼ -36.00K | ▲ -26.00K | ▲ 0.00 |
Debt Repayment | -453.00K | ▲ 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Common Stock Issued | 364.00K | ▲ 4.38M | ▼ 0.00 | 0.00 | ▲ 1.05M | ▼ 812.00K | ▲ 2.20M |
Common Stock Repurchased | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -330.00K | ▼ -1.93M | ▲ -1.00K |
Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | ▲ 582.00K | ▼ 112.00K | ▲ 239.00K | ▼ 26.00K | ▲ 812.00K | ▼ -1.00K |
Net Cash Used Provided By Financing Activities | -89.00K | ▲ 4.97M | ▼ 112.00K | ▲ 239.00K | ▲ 748.00K | ▲ 812.00K | ▲ 2.20M |
Effect Of Forex Changes On Cash | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 10.75M | ▼ 0.00 |
Net Change In Cash | -9.42M | ▲ -5.18M | ▲ -2.27M | ▲ 198.00K | ▼ -9.62M | ▲ -8.63M | ▼ -9.48M |
Cash At End Of Period | 50.99M | ▼ 11.21M | ▲ 17.34M | ▲ 23.80M | ▼ 11.88M | ▲ 15.69M | ▼ 6.21M |
Cash At Beginning Of Period | 60.41M | ▼ 16.39M | ▲ 19.61M | ▲ 23.60M | ▼ 21.50M | ▲ 24.32M | ▼ 15.69M |
Operating Cash Flow | -9.69M | ▼ -10.12M | ▲ -8.75M | ▼ -9.84M | ▼ -10.33M | ▲ -9.42M | ▼ -11.68M |
Capital Expenditure | 357.00K | ▼ -26.00K | ▼ -379.00K | ▲ -199.00K | ▲ -36.00K | ▲ -26.00K | ▲ 0.00 |
Free Cash Flow | -9.33M | ▼ -10.15M | ▲ -9.13M | ▼ -10.04M | ▼ -10.37M | ▲ -9.44M | ▼ -11.68M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
Generating AI Summary...
(This could take up to 5 minutes)